1,116 results on '"Polman, C"'
Search Results
2. Cytokines And Multiple Sclerosis : Implications for Treatment
3. Therapeutic Strategies in Multiple Sclerosis: The Value of Plasma Exchange
4. The Expression of Ia Antigen in the Course of Acute and Relapsing Experimental Allergic Encephalomyelitis in the Lewis Rat
5. Drug Treatment Of Multiple Sclerosis
6. Regular Review: Drug Treatment Of Multiple Sclerosis
7. Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis
8. Short-term adaptation to a simple motor task: A physiological process preserved in multiple sclerosis
9. Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis
10. Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis
11. A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility
12. BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis
13. Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis
14. Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT
15. Structural degree predicts functional network connectivity: A multimodal resting-state fMRI and MEG study
16. A dam for retrograde axonal degeneration in multiple sclerosis?
17. A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome
18. Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: An MEG source-space study
19. The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
20. The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis
21. Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition
22. A three-year, multi-parametric MRI study in patients at presentation with CIS
23. Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b
24. Does high-field MR imaging improve cortical lesion detection in multiple sclerosis?
25. MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: A review of reported findings
26. Neutralising antibodies to interferon β in multiple sclerosis: Expert panel report
27. A subtype of multiple sclerosis defined by an activated immune defense program
28. The distribution of magnetic resonance imaging response to interferonβ–1b in multiple sclerosis
29. Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of Interferon beta-1b in patients with Secondary Progressive Multiple Sclerosis
30. Multiple sclerosis and vitamin D: an update
31. Diagnosis and Management of Neuromyelitis Optica
32. Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis
33. Comparison of a conventional cardiac-triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesions in multiple sclerosis
34. Spinal cord magnetic resonance imaging in suspected multiple sclerosis
35. Factor structure of the Disability and Impact Profile in patients with multiple sclerosis
36. T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis
37. EFNS guidelines on diagnosis and management of neuromyelitis optica
38. Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study
39. Monoclonal antibodies for MS therapy: natalizumab: MT 2-1
40. Lack of interferon-beta bioactivity is associated with the occurrence of relapses in multiple sclerosis
41. Reduced hippocampal and thalamic activation patterns during memory encoding in MS
42. Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease
43. Diffusely Abnormal White Matter in Chronic Multiple Sclerosis: Imaging and Histopathologic Analysis
44. Clinical Correlations of Brain Lesion Distribution in Multiple Sclerosis
45. Serum homocysteine levels in relation to clinical progression in multiple sclerosis
46. Proxy ratings from multiple sources: disagreement on the impact of multiple sclerosis on daily life
47. Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters
48. Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study
49. No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up
50. Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.